(G.N.S) Dt. 23 London “As part of our recently expanded inbound vaccination policy, we recognise the following vaccines Pfizer BioNTech, Oxford AstraZeneca, Moderna and Janssen (J&J), for the purposes of international travel. This now includes the formulations AstraZeneca Covishield, AstraZeneca Vaxzevria and Moderna Takeda,” a UK government spokesperson said. “Our top priority remains protecting public health, and reopening travel in a safe and sustainable way, which is why vaccine certification
This content is restricted to site members. If you are an existing user, please log in. New users may register below.